| |
|
|
|
|
|
|
|||
|
Blood, 15 April 2007, Vol. 109, No. 8, pp. 3342-3350. Prepublished online as a Blood First Edition Paper on December 19, 2006; DOI 10.1182/blood-2006-09-046698.
Submitted September 11, 2006
Dept of Pathology & Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA * Corresponding author; email: dallman{at}mail.med.upenn.edu.
How diverse environmental cues are integrated to regulate B cell activation and development remains poorly understood. Here we show that Notch activity synergizes with B cell receptor and/or CD40 signaling to enhance several aspects of B cell activation and function. We find that co-stimulation of follicular B cells with the Notch ligand Delta-like-1 leads to significant increases in BCR- and CD40-mediated proliferation, and enhances production of IgG1+ cells in vitro and in vivo. We further find that co-engagement of Notch and the BCR results in increased activation of the MAPK pathway, and MAPK and Notch inhibitors prevent B cell activation events mediated by co-engagement of Notch and the BCR. These data suggest that the BCR and CD40 signaling pathways collaborate with the Notch pathway to optimize B cell activation.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||